New 52 Week High Today

GeneDx Holdings Corp WGS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/16/24 EDT
24.02UNCH (UNCH)
Volume
67,401
Close
24.02UNCH (UNCH)
Volume
558,776
52 week range
1.16 - 24.32
Loading...
  • Open22.32
  • Day High24.32
  • Day Low21.50
  • Prev Close21.16
  • 52 Week High24.32
  • 52 Week High Date05/16/24
  • 52 Week Low1.16
  • 52 Week Low Date11/16/23

Key Stats

  • Market Cap628.144M
  • Shares Out26.15M
  • 10 Day Average Volume0.73M
  • Dividend-
  • Dividend Yield-
  • Beta2.33
  • YTD % Change669.45

KEY STATS

  • Open22.32
  • Day High24.32
  • Day Low21.50
  • Prev Close21.16
  • 52 Week High24.32
  • 52 Week High Date05/16/24
  • 52 Week Low1.16
  • 52 Week Low Date11/16/23
  • Market Cap628.144M
  • Shares Out26.15M
  • 10 Day Average Volume0.73M
  • Dividend-
  • Dividend Yield-
  • Beta2.33
  • YTD % Change669.45

RATIOS/PROFITABILITY

  • EPS (TTM)-5.25
  • P/E (TTM)-4.58
  • Fwd P/E (NTM)-15.94
  • EBITDA (TTM)-90.286M
  • ROE (TTM)-50.41%
  • Revenue (TTM)221.849M
  • Gross Margin (TTM)50.57%
  • Net Margin (TTM)-60.86%
  • Debt To Equity (MRQ)25.24%

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On GeneDx Holdings Corp

 

Profile

MORE
GeneDx Holdings Corp. is a genomics company. The Company is focused on delivering personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The Company's segments are GeneDx inclusive of Legacy GeneDx and Legacy Sema4. The GeneDx segment primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. GeneDx utilizes an...
Jason Ryan CPA
Executive Chairman of the Board
Katherine Stueland
Chief Executive Officer, Director
Kevin Feeley
Chief Financial Officer
Address
333 Ludlow Street
North Tower, 8Th Floor
Stamford, CT
06902
United States